14 results on '"King TF"'
Search Results
2. Proton-pump inhibitor use amongst patients with severe hypomagnesemia.
- Author
-
Seah S, Tan YK, Teh K, Loh WJ, Tan PT, Goh LC, Malakar RD, Aw TC, Lau CS, Dhalliwal T, Kui SL, Kam JW, Khoo J, Tay TL, Tan E, Au V, Soh SB, Zhang M, King TF, Gani L, and Puar TH
- Abstract
Introduction: Long-term proton pump inhibitor (PPI) use has been associated with hypomagnesemia. It is unknown how frequently PPI use is implicated in patients with severe hypomagnesemia, and its clinical course or risk factors. Methods: All patients with severe hypomagnesemia from 2013 to 2016 in a tertiary center were assessed for likelihood of PPI-related hypomagnesemia using Naranjo algorithm, and we described the clinical course. The clinical characteristics of each case of PPI-related severe hypomagnesemia was compared with three controls on long-term PPI without hypomagnesemia, to assess for risk factors of developing severe hypomagnesemia. Results: Amongst 53,149 patients with serum magnesium measurements, 360 patients had severe hypomagnesemia (<0.4 mmol/L). 189 of 360 (52.5%) patients had at least possible PPI-related hypomagnesemia (128 possible, 59 probable, two definite). 49 of 189 (24.7%) patients had no other etiology for hypomagnesemia. PPI was stopped in 43 (22.8%) patients. Seventy (37.0%) patients had no indication for long-term PPI use. Hypomagnesemia resolved in most patients after supplementation, but recurrence was higher in patients who continued PPI, 69.7% versus 35.7%, p = 0.009. On multivariate analysis, risk factors for hypomagnesemia were female gender (OR 1.73; 95% CI: 1.17-2.57), diabetes mellitus (OR, 4.62; 95% CI: 3.05-7.00), low BMI (OR, 0.90; 95% CI: 0.86-0.94), high-dose PPI (OR, 1.96; 95% CI: 1.29-2.98), renal impairment (OR, 3.85; 95% CI: 2.58-5.75), and diuretic use (OR, 1.68; 95% CI: 1.09-2.61). Conclusion: In patients with severe hypomagnesemia, clinicians should consider the possibility of PPI-related hypomagnesemia and re-examine the indication for continued PPI use, or consider a lower dose., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Seah, Tan, Teh, Loh, Tan, Goh, Malakar, Aw, Lau, Dhalliwal, Kui, Kam, Khoo, Tay, Tan, Au, Soh, Zhang, King, Gani and Puar.)
- Published
- 2023
- Full Text
- View/download PDF
3. Incidence of Atypical Femoral Fracture and Its Mortality in a Single Center in Singapore.
- Author
-
Gani L, Anthony N, Dacay L, Tan P, Chong LR, and King TF
- Abstract
Bisphosphonates (BP) are the most commonly prescribed effective form of osteoporosis treatment with adverse effects associated with prolonged use such as atypical femoral fractures (AFF). Asians have an elevated risk of AFF at 5 to 6 times those of whites and Hispanics. In this study, we characterize factors associated with AFF and its mortality in a single center in Singapore. We conducted a cohort study of subjects older than 50 years admitted to Changi General Hospital (CGH), Singapore, with fragility subtrochanteric femoral fractures from 2009 to 2015. Using the ASBMR 2014 criteria, fractures are classified into atypical and typical subtrochanteric femoral fractures. CGH uses a nationalized electronic health record that allows review of information on patients' demographics, clinical history and previous investigations. Mortality was assessed as of December 31, 2019. Between 2009 and 2015, there were 3097 hip fractures, of which 393 were subtrochanteric femoral fractures and 69 were classified as AFF by ASBMR 2014 criteria. A total of 52.2% of AFF occurred with BP exposure of median duration 56.5 (28 to 66) months. Multivariate regression showed that BP exposure was associated with the highest risk of AFF (odds ratio [OR] = 6.65 [2.35-18.9]). AFF patients had higher 5-year survival (0.85 versus 0.62, p = 0.001) compared with typical subtrochanteric fracture patients. However, after adjusting for variables, the type of subtrochanteric femoral fractures were no longer significantly associated with progression to death, whereas older age, higher mean Charlson comorbidity score, and Malay ethnicity were the strongest predictors of death. AFF constitutes a small proportion of hip and femoral fractures with prolonged BP use being the highest risk factor for its development. There is no evidence of increased mortality or morbidity in patients with AFF compared with the typical subtrochanteric fracture. The fear of AFF should not impede treatment of typical osteoporotic fractures in this population. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., (© 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.)
- Published
- 2021
- Full Text
- View/download PDF
4. Outcomes in unilateral primary aldosteronism after surgical or medical therapy.
- Author
-
Puar TH, Loh LM, Loh WJ, Lim DST, Zhang M, Tan PT, Lee L, Swee DS, Khoo J, Tay D, Tan SY, Zhu L, Gani L, King TF, Kek PC, and Foo RS
- Subjects
- Adrenal Glands, Adrenalectomy, Humans, Prognosis, Retrospective Studies, Hyperaldosteronism drug therapy, Hyperaldosteronism surgery, Models, Statistical
- Abstract
Context: Studies find surgery superior to medications in the treatment of primary aldosteronism (PA). It would be ideal to compare surgical and medical therapy in patients with unilateral PA only, who have the option between these treatment modalities. However, this is challenging as most patients with unilateral PA on adrenal vein sampling (AVS) undergo surgery., Objective: To compare outcomes of surgery and medications in patients with confirmed or likely unilateral PA., Design: Retrospective cohort study of 274 patients with PA managed at two referral centres from 2000 to 2019., Patients: 154 patients identified with unilateral PA using AVS and a validated clinical prediction model were treated with surgical (n = 86) or medical (n = 68) therapy., Measurements: Primary outcome was a composite incident cardiovascular event comprising acute myocardial infarction, coronary revascularization, stroke, atrial fibrillation or congestive cardiac failure. Secondary outcomes were clinical and biochemical control., Results: Cardiovascular outcomes were comparable, with the surgery group having an adjusted hazard ratio of 0.93 (95% CI: 0.32-2.67), p = .89. Both treatments improved clinical and biochemical control, but surgery resulted in better systolic blood pressure, 133.0 ± 11.7 mmHg versus 137.9 ± 14.6 mmHg, p = .02, and lower defined daily dosages of antihypertensive medications, 1.0 (IQR 0.0-2.0) versus 2.6 (IQR 0.8-4.3), p < .001. In addition, 12 of 86 patients in the surgery group failed medical therapy before opting for surgery., Conclusion: In patients with unilateral PA who can tolerate medications, medical therapy improves clinical and biochemical control, and may offer similar cardiovascular protection. However, surgery reduces pill burden, may cure hypertension and is recommended for unilateral PA., (© 2020 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
5. Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
- Author
-
King TF, Lee MC, Williamson EE, and Conway GS
- Subjects
- Adolescent, Adrenal Rest Tumor diagnostic imaging, Adult, Follicle Stimulating Hormone analysis, Humans, Infertility, Male diagnosis, Luteinizing Hormone analysis, Male, Middle Aged, Reproductive Techniques, Assisted, Retrospective Studies, Semen Analysis, Testicular Neoplasms diagnostic imaging, Treatment Outcome, Ultrasonography, Young Adult, Adrenal Hyperplasia, Congenital complications, Infertility, Male etiology, Infertility, Male therapy
- Abstract
Objective: Men with congenital adrenal hyperplasia (CAH) have impaired fertility. We aimed to assess fertility outcomes and the importance of hypogonadotropic hypogonadism, testicular failure and the presence of testicular adrenal rest tumours (TART)., Design: Retrospective analysis of men attending an adult CAH clinic in a tertiary centre., Patients: Fifty men with CAH due to 21 hydroxylase deficiency were identified of whom 35 were salt wasting and 15 were non-salt-wasting., Measurements: Review of fertility history and parameters including luteinizing hormone (LH), follicle-stimulating hormone (FSH), androstenedione, 17-hydroxyprogesterone (17-OHP), semen analysis and the presence of testicular adrenal rest tissue (TART) on ultrasound., Results: TART were detected by ultrasound in 21 (47%), and their presence was associated with an elevated FSH (P = 0·01). Severe oligospermia was present in 11 of 23 (48%), and this was associated with an elevated FSH (P = 0·02), suppressed LH (P < 0·01) and TART (P = 0·03) when compared to those with a sperm count >5 × 10(6) per ml. Of those that desired fertility, 10 of 17 (59%) required treatment intensification and four underwent in vitro fertilization. Intensification resulted in a rise in median LH (0·6-4·3 IU/l; P = 0·01). Live birth rate was 15 of 17 (88%) with a median (range) time to conception of 8 (0-38) months., Conclusions: Suppressed LH is a marker for subfertility and is often reversible. Testicular failure is closely associated with TART formation. If TART are detected, sperm cryopreservation should be offered given the risk of progression to irreversible testicular failure. Male fertility in CAH can be improved by intensified treatment and assisted reproductive technology., (© 2015 John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
6. Swyer syndrome.
- Author
-
King TF and Conway GS
- Subjects
- Bone Density, Early Diagnosis, Female, Fertility Preservation methods, Gonadal Dysgenesis, 46,XY drug therapy, Gonadal Dysgenesis, 46,XY pathology, Humans, Neoplasms, Germ Cell and Embryonal drug therapy, Neoplasms, Germ Cell and Embryonal pathology, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Prognosis, Sexual Development, Gonadal Dysgenesis, 46,XY diagnosis, Gonadal Steroid Hormones therapeutic use, Hormone Replacement Therapy, Neoplasms, Germ Cell and Embryonal prevention & control, Ovarian Neoplasms prevention & control
- Abstract
Purpose of Review: This review focuses on the pathogenesis, diagnosis, management and long-term outcomes of disorders of sex development, specifically women with Swyer syndrome (46,XY complete gonadal dysgenesis)., Recent Findings: Recent discoveries have broadened our understanding of the complex pathways involved in normal and abnormal sex development. In 46,XY gonadal dysgenesis, lack of testis development may be triggered by sex determining region Y, NR5A1, DHH or testis-determining gene loss-of-function mutations, DAX1 or WNT4 duplication or MAP3K1 gain-of-function mutations. The diagnosis and management of patients with Swyer syndrome is complex, and optimal care requires an experienced multidisciplinary team. Early diagnosis is vital because of the significant risk of germ cell tumour, and bilateral gonadectomy should be performed. Furthermore, early sex hormone treatment is necessary to induce and maintain typical pubertal development and to achieve optimal bone mineral accumulation. Pregnancy is possible via ova donation, and outcomes are similar to women with 46,XX ovarian failure., Summary: Further pathogenic gene mutations are likely to be identified, and the function, interaction and phenotypic effects of new and existing mutations will be further defined. Patients require long-term follow-up in specialist centres.
- Published
- 2014
- Full Text
- View/download PDF
7. Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report.
- Author
-
Crowley RK, Kilbane M, King TF, Morrin M, O'Keane M, and McKenna MJ
- Abstract
Introduction: This is the first report of which the authors are aware to describe this c.2166delinsGG mutation in X-linked hypophosphataemia and to describe normalisation of renal threshold for phosphate excretion after parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia., Case Presentation: We present the case of a 34-year-old Caucasian woman with X-linked hypophosphataemia. She developed tertiary hyperparathyroidism with markedly high bone turnover requiring total parathyroidectomy and had prolonged requirement for intravenous calcium infusion after surgery. She had a novel mutation in her phosphate-regulating gene with homologies to endopeptidases on the X-chromosome and had an unusual degree of dependence on phosphate supplementation. Prior to operative intervention she had a trial of cinacalcet that improved bone turnover markers when used in isolation but which led to a paradoxical rise in parathyroid hormone levels when given with phosphate supplementation. After correction of hungry bone syndrome, the renal phosphorus threshold normalised as a manifestation of hypoparathyroid state despite marked elevation in level of fibroblast growth factor 23., Conclusions: This case illustrates the risk of tertiary hyperparathyroidism as a complication of treatment for hypophosphataemia; it highlights the morbidity associated with hungry bone syndrome and provides novel insight into renal handling of phosphorus.
- Published
- 2014
- Full Text
- View/download PDF
8. Endothelial progenitor cells and cardiovascular disease.
- Author
-
King TF and McDermott JH
- Subjects
- Animals, Endothelial Progenitor Cells physiology, Humans, Risk Factors, Cardiovascular Diseases therapy, Endothelial Progenitor Cells cytology
- Abstract
Endothelial Progenitor Cells (EPCs) are bone-marrow derived stem cells that are postulated to contribute to post-natal vasculogenesis and to repair of damaged endothelium by incorporation into the vessel wall, secretion of paracrine hormones and stimulation of angiogenesis. Since the first description of the putative EPCs in 1997, and the role of these cells in neovascularisation of mouse and rabbit ischaemic limbs was originally described, there has been an explosion of research into the role of EPCs in human cardiovascular disease. There is now a large body of direct and indirect evidence to support an important role for EPCs in cardiovascular disease processes. This book chapter explores the following: 1. Correlation between EPCs and other cardiovascular risk markers 2. EPCs in patients with established cardiovascular disease 3. Reversible defects in EPC number and function in patients with an increased cardiovascular risk 4. Statins and EPC biology 5. The effect on EPCs of other interventions known to reduce cardiovascular risk - EPCs and treatment of diabetes, hypertension, subclinical hypothyroidism 6. Beneficial effects of EPC-based therapies animal models of ischaemia 7. Human Studies of EPC-based therapies A lower level of circulating EPCs and reduced EPC function in vitro are associated with an increased cardiovascular risk. The accumulated evidence suggests that a balance between the damaging effects of conventional cardiovascular risk factors and the ability of circulating EPCs to affect endothelial repair determines this cardiovascular risk.
- Published
- 2014
- Full Text
- View/download PDF
9. Results of iliac stenting and aortofemoral grafting for iliac artery occlusions.
- Author
-
Sachwani GR, Hans SS, Khoury MD, King TF, Mitsuya M, Rizk YS, Zachwieja JA, and Sayed L
- Subjects
- Aged, Angioplasty, Balloon adverse effects, Angioplasty, Balloon mortality, Ankle Brachial Index, Blood Vessel Prosthesis Implantation adverse effects, Blood Vessel Prosthesis Implantation mortality, Constriction, Pathologic, Female, Humans, Iliac Artery physiopathology, Kaplan-Meier Estimate, Length of Stay, Male, Michigan, Middle Aged, Multivariate Analysis, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease mortality, Peripheral Arterial Disease physiopathology, Peripheral Arterial Disease surgery, Proportional Hazards Models, Registries, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Vascular Patency, Angioplasty, Balloon instrumentation, Aorta surgery, Blood Vessel Prosthesis Implantation methods, Femoral Artery surgery, Iliac Artery surgery, Peripheral Arterial Disease therapy, Stents
- Abstract
Objective: To compare long-term results of percutaneous iliac artery stenting (PCIS) with aortobifemoral (ABF) grafting for patients with symptomatic iliac artery occlusions., Methods: A retrospective review of 229 patients (January 2000 to December 2011) with symptomatic iliac artery occlusions was performed. In 100 patients, 103 PCIS procedures were performed, and 101 patients underwent ABF grafting. Outcome data including periprocedural complications, improvement in ankle-brachial index, morbidity, and mortality were collected in a vascular registry. Kaplan-Meier estimates for patency and survival were analyzed. Univariate (Fisher exact test) and multivariate analyses of variables associated with the loss of primary patency were performed., Results: Patients in the ABF grafting group were younger (60 ± 0.9 years old vs 65 ± 1.2 years old; P = .002) and more commonly had a history of nicotine abuse (97% vs 86%; P = .002), chronic obstructive pulmonary disease (85% vs 70%; P = .02), and a greater incidence of superficial femoral artery disease (45% vs 24%; P = .001). The most common presenting symptoms in both groups consisted of intermittent claudication (66% ABF vs 71% PCIS), rest pain (20% ABF vs 17% PCIS), and ulceration or gangrene of toes (14% ABF vs 15% PCIS). At 72 months, the primary patency for ABF bypass was greater than for PCIS (91% vs 73%; P = .010). Secondary patency rates were equivalent in both groups (98% ABF vs 85% PCIS). Survival in the ABF bypass group was significantly greater than in the PCIS group (76% vs 68%; P = .013). Hyperlipidemia (hazard ratio, 2.55; P = .049) and concurrent superficial femoral artery lesion (hazard ratio, 2.61; P = .026) were factors associated with the loss of primary patency for the entire cohort. The average hospital stay was 7 ± 2 days in the ABF group and 1 ± 0.3 days in the PCIS group (P = .0001). There were no periprocedural deaths in the PCIS group; there were four deaths in the ABF group (P = .058). In the PCIS group, ankle-brachial index increased from 0.66 to 0.89, and in the ABF group, ankle-brachial index increased from 0.54 to 0.98 (both groups, P < .001)., Conclusions: This study demonstrates that PCIS remains a suitable, less invasive first-line therapy for iliac artery occlusions. PCIS has lower morbidity, shorter hospital length of stay, and equivalent secondary patency but inferior primary patency compared with ABF., (Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
10. Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk?
- Author
-
King TF, Bergin DA, Kent EM, Manning F, Reeves EP, Dicker P, McElvaney NG, Sreenan S, Malone FD, and McDermott JH
- Subjects
- Adult, Cells, Cultured, Cohort Studies, Endothelial Cells cytology, Female, Fetal Growth Retardation etiology, Fetal Growth Retardation physiopathology, Hematopoietic Stem Cells cytology, Humans, Infant, Newborn, Infant, Small for Gestational Age physiology, Placenta pathology, Placenta Diseases etiology, Placenta Diseases physiopathology, Pregnancy, Prenatal Exposure Delayed Effects etiology, Risk Factors, Cardiovascular Diseases etiology, Endothelial Cells physiology, Hematopoietic Stem Cells physiology, Infant, Low Birth Weight, Mothers, Neovascularization, Pathologic complications, Placenta blood supply
- Abstract
Context: Offspring birthweight is inversely associated with future maternal cardiovascular mortality, a relationship that has yet to be fully elucidated. Endothelial progenitor cells (EPCs) are thought to play a key role in vasculogenesis, and EPC numbers reflect cardiovascular risk., Objective: Our objective was to ascertain whether EPC number or function was reduced in mothers of low-birthweight infants., Design and Setting: This was a prospective cohort study in a general antenatal department of a university maternity hospital., Participants: Twenty-three mothers of small for gestational age (SGA) infants (birthweight < 10th centile) and 23 mothers of appropriate for gestational age (AGA) infants (birthweight ≥ 10th centile) were recruited., Main Outcome Measures: Maternal EPC number and function, conventional cardiovascular risk markers, and cord blood adiponectin were measured., Results: Median EPC count was lower (294 vs. 367, P = 0.005) and EPC migration was reduced (0.91 vs. 1.59, P < 0.001) in SGA compared with AGA infants, with no difference in EPC adhesion (0.221 vs. 0.284 fluorescence units, P = 0.257). Maternal triglyceride levels were higher in SGA than AGA infants (0.98 vs. 0.78 mmol/liter, P = 0.006), but there was no difference in cholesterol, glucose, insulin, glycosylated hemoglobin, adiponectin, or blood pressure. There was a moderate monotone (increasing) relationship between birthweight and umbilical cord blood adiponectin (r = 0.475, P = 0.005)., Conclusion: Giving birth to an SGA infant was associated with lower maternal EPC number and reduced migratory function. Cord blood adiponectin was significantly correlated with birthweight.
- Published
- 2013
- Full Text
- View/download PDF
11. A case of stiff-person syndrome, type 1 diabetes, celiac disease and dermatitis herpetiformis.
- Author
-
O'Sullivan EP, Behan LA, King TF, Hardiman O, and Smith D
- Subjects
- Adult, Celiac Disease physiopathology, Comorbidity, Dermatitis Herpetiformis physiopathology, Diabetes Mellitus, Type 1 physiopathology, Humans, Male, Stiff-Person Syndrome physiopathology, Celiac Disease diagnosis, Dermatitis Herpetiformis diagnosis, Diabetes Mellitus, Type 1 diagnosis, Stiff-Person Syndrome diagnosis
- Abstract
Antibodies against glutamic acid decarboxylase (GAD) are involved in the pathophysiology of stiff-person syndrome (SPS) and type 1 diabetes. GAD catalyses the conversion of glutamate to gamma-aminobutyric acid (GABA). GABA acts as a neurotransmitter between neurones, while in pancreatic beta cells it plays an integral role in normal insulin secretion, hence the clinical presentation of muscular spasms in SPS and insulin deficiency in diabetes. Despite this apparent major overlap in pathophysiology, SPS only rarely occurs in individuals with type 1 diabetes. We report the case of a 41-year-old man presenting with a simultaneous diagnosis of both these conditions. His case is unusual in that it is the first reported case in the literature of these conditions occurring in someone with celiac disease (CD) and dermatitis herpetiformis. We discuss why SPS and type 1 diabetes co-exist in only a minority of cases and speculate on the underlying mechanism of the association with CD and dermatitis herpetiformis in our patient.
- Published
- 2009
- Full Text
- View/download PDF
12. An apparent phaeochromocytoma and abnormal thyroid function tests.
- Author
-
King TF, Shea PO, Sullivan EP, Srinivasan R, Griffin A, Fitzgerald R, Tormey W, and Smith D
- Subjects
- Adrenal Glands diagnostic imaging, Adult, Epinephrine urine, Female, Humans, Metanephrine urine, Normetanephrine urine, Thyroid Function Tests, Tomography, X-Ray Computed, Adrenal Gland Neoplasms diagnosis, Pheochromocytoma diagnosis
- Abstract
A 41-year-old lady presented with classical symptoms of a phaeochromocytoma and markedly elevated urinary adrenaline concentration. Urinary fractionated metanephrine and normetanephrine concentrations were within the normal reference range. Computed tomography of the abdomen/pelvis and I(123) meta-iodobenzylguanidine scans were negative. Factitious adrenaline use was established as the diagnosis.
- Published
- 2008
- Full Text
- View/download PDF
13. Physical analysis of the region deleted in the tw18 allele of the mouse tcl-4 complementation group.
- Author
-
Barclay J, King TF, Crossley PH, Barnard RC, Larin Z, Lehrach H, and Little PF
- Subjects
- Animals, Chromosome Walking, Chromosomes, Artificial, Yeast genetics, DNA Probes, Genetic Complementation Test, Genetic Markers, Mice, Mice, Inbred C57BL, Recombination, Genetic, Restriction Mapping, Alleles, Chromosome Deletion, Embryonic and Fetal Development genetics, Gastrula
- Abstract
We have generated a YAC contig of at least 3.3 Mb from the proximal region of In(17)4 of mouse chromosome 17. This region corresponds to DNA lost in the gastrulation mutant tw18, which belongs to the tcl-4 complementation group. Our most proximal and distal probes lie within the deletion-3.3 Mb apart-indicating that we have not cloned the entire region. The deleted region is contained in a genetic interval of less than 1 cM, suggesting that some suppression of recombination must occur.
- Published
- 1996
- Full Text
- View/download PDF
14. Development and implementation of a pharmacy technician training program.
- Author
-
Kaufman RL, Pistocco LF, Cotnoir GM, Fisher KN, King TF, and Phillips EA
- Subjects
- Adolescent, Adult, Age Factors, Curriculum, Female, Humans, Male, Medication Systems, Hospital, Middle Aged, Pharmacy Technicians standards, Rhode Island, Sex Factors, Time Factors, Training Support, Workforce, Pharmacy Service, Hospital, Pharmacy Technicians education
- Abstract
A nine-month on-the-job training program for hospital pharmacy technicians is described. The first three months of the program are devoted to didactic training and the remaining six months to acquiring practical experience. Candidates for the program are provided through state-sponsored public assistance or manpower training programs. A minimum of six individuals are needed to begin a program to ensure that during at least three complete it. Forth technicians have completed the program during the past six years, and eight are currently employed by the hospital. Thirteen others are known to be employed at other institutions or in health-related occupations.
- Published
- 1975
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.